Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / AKRO - Akero Therapeutics: A NASH Pureplay With Differentiated Mid Stage Data

AKRO - Akero Therapeutics: A NASH Pureplay With Differentiated Mid Stage Data

Akero Therapeutics Inc.
  • AKRO has produced highly competitive phase 2a data and has a phase 2b running with data later this year.
  • NASH is a vast market and AKRO looks like the real deal in the space.
  • The company is adequately financed for the next 18 months at the least.

For further details see:

Akero Therapeutics: A NASH Pureplay With Differentiated Mid Stage Data
Stock Information
Company Name: Akero Therapeutics Inc.
Stock Symbol: AKRO
Market: NYSE
Website: akerotx.com
Menu
AKRO AKRO Quote AKRO Short AKRO News AKRO Articles AKRO Message Board
Get AKRO Alerts

News, Short Squeeze, Breakout and More Instantly...